CytoDyn to Present New Data from Study of Investigational HIV Therapy Leronlimab (PRO 140), a Long-Acting, Single-Agent Maintenance Therapy at CROI 2019

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice